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The treatment trial being reported investigated 
whether the frequency and severity of pain in 11 
patients with chronic intractable angina pectoris 
were decreased by TENS applied adjacent to T, 
and Ts spinous processes. Pulse and blood 
pressure were measured before, during and 
aUereach treatment. Results showed a. 
significant decrease in frequency and severity 
of pain. Hate pressure product was calculated 
tu try to identify the mode of action. The mean 
RPP before TENS application. compared with 
the mean RPP at 30 minutes and at 90 minutes, . 
was significantly reduced. It was concluded 
from these results that TENS should be 
considered as an adjunct to medical 
management in those patients with angina 
pectoris not satisfactori Iy controlled by opti mal 
medication. " 
[NitzJCandCheras F: Transcutaneous electrical 
nerve stimulation and chronic intractable angina 
pectoriS. Australian Journal of Physiotherapy 
39: 109-113] 
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ORIGINAL ARTICLE 
Transcutaneous electrical 
nerve stimulation 
and chronic intractable 
angina pectoris 
The term angina pectoris was first used by Heberden to describe the 
pain of cardiac origin (Procacci 
and Maresca 1985). Ischaemia has been 
identified as the cause of cardiac pain. 
It increases sensory nerve activity in 
the adventitia of coronary arteries, the 
myocardium and the subepicardial 
tissue. Metabolites associated with 
ischaemia may contribute to the 
stimulation of pain receptors. Sensory 
and pain afferent impulses from the . 
heart are transmitted to the central 
nervous system via fibres in the cervical 
and thoracic sympathetic nerves. 
These reach the spinal cord via the 
upper four or five thoracic dorsal nerve 
roots (Mannheimer et al 1985, 
Procacci and Maresca 1985). This 
neurological input would account for 
the variable distribution of the pain 
perceived during episodes of angina 
pectoris. It has been postulated that the 
pain of angina pectoris may secondarily 
increase myocardial ischaemia by 
increasing sympathetic activity 
(Mannheimer et al 1982). 
At some stage in the medical 
management of chronic intractable 
angina pectoris, optimal levels of 
medication no longer control the 
resting or exercise induced pain 
suffered by a number of patients. 
Often, these people have had coronary 
artery bypass surgery or have 
inoperable coronary artery disease. As 
a consequence, their life~style has 
become severely restricted and the 
frequency of hospital admissions is 
high. 
Transcutaneous electrical nerve 
stimulation (TENS) has been in use 
for a number of decades for the 
management of pain. Its mode of 
action is still under investigation but it 
appears that variable stimulation 
modalities lead to a variety of 
neurological, histochemical and 
neuropharmacological responses 
(Gersh and Wolf 1985). When TENS 
is used to manage cardiac pain it not 
only works in the expected pain 
relieving manner, but also appears to 
suppress sympathetic activity 
(Mannheimer et al 1985, Procacci and 
Maresca 1985). To date, no studies 
have been undertaken to establish the 
effect of TENS on angina, which do 
not require the patient to perform 
work. 
In an attempt to improve the quality 
of life in patients with chronic 
intractable angina pectoris, one of the 
cardiac physicians at Greenslopes 
Repatriation Hospital in Brisbane 
referred the first patient to the 
Physiotherapy Department for a trial 
of TENS to help control the angina. 
As no physiotherapist on the staff had 
used TENS for this purpose, current 
guidelines for TENS application and 
the nerve supply to the heart were 
considered in developing a treatment 
method as well asa need for accurate 
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recording of the response to treatment. 
The clinical problem to be addressed 
was whether TENS could be used to 
reduce the disability caused by the pain 
and the frequency of occurrence of 
angina pectoris in the patients referred 
for treatment. The effect of treatment 
was assessed by comparing the 
intensity of pain and the frequency 
of angina attacks before and after a 
course of treatment. Also, blood 
pressure and heart rate were recorded 
before, during and after each 
treatment. 
The treatment protocol and the 
method of assessing its effect were 
approved by the Medical Ethics 
Committee of Greenslopes 
Repatriation Hospital. All patients 
gave informed consent. 
Method 
Eleven patients referred for treatment 
were included in the trial and treated 
with TENS for chronic intractable 
angina pectoris which was not 
controlled by maximal tolerated 
medication dosage. All were 
experiencing pain at rest or on minimal 
exertion due to activities of daily living 
such as showering, dressing, toilering 
or eating. They were extremely limited 
in life-style and quite unable to 
participate in normal activities 
undertaken by people of similar age. 
Those patients referred for a trial of 
treatment who lived outside Brisbane 
were usually kept as inpatients until the 
trial was completed. Those patients 
resident in Brisbane attended as 
outpatients. Although the use of 
placebo TENS in a similar group of 
patients to compare results to those 
treated was considered, an increase in 
length of hospital stay or number of 
outpatient attendances for this placebo 
group would have beencosdy if they 
were then to also trial treatment of 
TENS. 
To maintain maximal control of 
variables, the patients and medical staff 
cooperated to ensure there was no 
change in medication, diet or level of 
activity while the trial was underway. 
The same physiotherapist treated all 
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Figure 1. 
P<!.in levels and frequency of angina before and after the trial of TENS. 
A = after. B = before 
2 treatments per day 
_ _ _ _ _ _ _ 1treatment per day 
patients to eliminate interoperator 
error. 
The apparatus used was a Neuromod 
dual channel TENS unit delivering a 
biphasic exponentially decaying spike 
wave form stimulation with zero DC 
component, and an O.8msec pulse 
width at a rate of 85Hz. The stimulus 
was delivered by four carbonised 
rubber electrodes. Skin contact was 
maintained by electrode-conducting 
gel. All electrodes were secured in 
place with tape. The same mercury 
sphygmomanometer and stethoscope 
were·used for each measurement of 
blood pressure for all patients 
undertaken by the same person. 
Age, gender, diagnosis, past medical 
and surgical history, as well as current 
medication, were recorded for each 
patient. Ashort seven-response 
questionnaire indicating the patient's 
pain pattern was administered by the 
physiotherapist responsible for each 
treatment. This showed frequency of 
angina episodes, precipitating factors 
and how the pati~mt coped with the 
pain. It also showed the anatomical site 
of most pain. At the same time, the 
patient marked the first visual analogue 
pain scale (Melzack 1987) to indicate 
the usual severity of pain. 
Pulse and blood pressure were 
recorded prior to commencing 
treatment. The TENS electrodes were 
applied paraspinally adjacent to the 
spinous processes of the first and fifth 
thoracic vertebrae, one channel on 
each side. The intensity of the 
stimulation was turned up to a level 
perceived by the patient as 
comfortable. This amplitude was 
recorded on the patient information 
sheet and was kept constant 
throughout the 90 minute treatment 
time. Pulse and blood pressure were 
recorded 30 minutes after application 
and again when the TENS was turned 
off after 90 minutes. Each treatment 
was given at the same time each day, 
commencing at half past nine in the 
morning or half past one in the 
afternoon. Previous studies by 
Mannheimer et al (1982) reported 
using three one-hour sessions daily. 
However this was not practical in the 
present study, so 90 minute sessions 
were adopted. 
The treatment was repeated twice 
daily for 10 sessions for inpatients, or 
once daily for outpatients, who also 
received 10 treatments. Where 
possible, the trial was started on 
Monday and continued on consecutive 
days except weekends. There were 
seven patients who received twice daily 
treatments. The remaining four 
received one treatment each day, either 
morning or afternoon depending on 
the work load of the treating 
physiotherapist. During the treatment, 
the patient was not required to 
perform any specific task, but some 
read or watched television. Toilet 
privileges were allowed during 
treatment. 
Prior to the first treatment on 
subsequent days, the number of 
episodes of angina experienced during 
the previous 24 hours was recorded on 
the patienes data sheet. At the end of 
the tenth treatment session,a second 
visual analogue pain scale was 
completed. 
Results 
The 11 patients referred for treatment 
during the sb!:-month trial period were 
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Figure 2. 
Mean puise rate before, during and after TENS application for subjects 1 to 11. 
all males and ranged in age from 67 to 
81 years (average age 74.6 years). All 
were severely limited by angina in their 
ability to perform the normal activities 
of daily living. The complex medical 
picture seen in this age group was 
demonstrated by the questionnaire. Of 
the 11 patients, six had a history of 
myocardial infarction, five had 
arthritis, three had chronic obstructive 
airway disease, three had hypertension, 
one had atrial fibrillation, one had 
non-insulin dependent diabetes 
mellitus, one had a cerebrovascular 
accident and two had had coronary 
artery bypass surgery. Obviously, most 
patients had more than one medical 
problem. However, the disability due 
to the angina pectoris from ischaemic 
heart disease was the major factor 
limiting activity in all patients. 
The average daily frequency of 
angina episodes prior tb commencing 
treatment with TENS was compared 
with the average number of daily 
episodes at the end of the trial using a 
Wilcoxon test for paired observations. 
This showed a significant decrease in 
the number of episodes of angina 
during the trial (p<0;01). Apaired Hest 
was used to compare the results from 
the visual analogue pain scales. A 
significant reduction in intensity of 
perceived pain was demonstrated (t 0 = 
3.581, p<O.OOS). For each patient, ilie 
change in pain levels and the average 
frequency of angina episodes each day 
prior to the trial and after the trial are 
demonstrated in Figure 1. There was 
no difference in response to the TENS 
treatment in those patients receiving 
one or two treatments per day except 
that those receiving two treatments 
generally showed marked reduction in 
the frequency of severity of angina by 
the third day. Those patients receiving 
one treatment a day usually took five 
days to show this response. However, 
this observation could not be verified 
statistically:. 
In. an endeavour to determine how 
TENS achieved the reduction in pain 
and frequency of angina attacks, heart 
rate and blood pressure were measured 
before, during and after each 
treatment. Gobelet al (1987) and 
Kispert (1987) identified the rate 
pressure product (RPP), which is 
calculated from heart rate x systolic 
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blood pressure as an easily measured 
indicator of haemodynamic variables, 
namely myocardial oxygen uptake. 
Therefore the mean RPP before 
application of TENS was compared to 
the mean RPP at 30 minutes using a 
paired t-test. This was significantly 
reduced (tlO = 3.581,p<0.005) at 30 
minutes and further reduced after 90 
minutes (tlO = 4.587,p<0.001). There 
was no significant difference between 
mean RPP at 30 minutes and mean 
RPP at 90 minutes. The mean pulse 
rate taken for each patient before, at 30 
minutes into the treatment and after 90 
minutes compiled from data collected 
at each treatment, are shown in Figure 
2. Most patients show a downward 
trend. 
Discussion 
The results of this trial showed a very 
significant reduction in the frequency 
and severity of anginal episodes over 
the period of 10 treatment sessions. 
Subjectively, at least 50 per cent 
reduction in frequency of pain level 
was noted by the fifth or sixth 
treatment irrespective of whether the 
patients were having one or two 
treatments daily. 
The 11 patients who participated 
were older (mean age 74.6 years) than 
those previously studied (Mannheimer 
et al1982 and 1985, Murphy and Giles 
1987). 
In other investigations where TENS 
was used for patients with angina 
pectoris, the electrodes were 
positioned on the chest wall over the 
site of most intense pain (Mannheimer 
et al1982 and 1985). The rationale for 
such electrode placement was for pain 
blocking with a presumed effect on 
sympathetic outflow. In the treatment 
trial reported here, the TENS 
electrodes were placed paraspinallyat 
the levelofT,and Ts in an attempt to 
directly affect both the sensory input 
and the sympathetic output. This non-
invasive placement of electrodes was 
based on a rationale similar to that 
reported by Murphy and Giles (1987) 
where dorsalcol:umrt epidural 
stimulation was used to treat 
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intractable angina pectoris. The 
resultant decrease in pain and 
frequency of angina in the present 
group of patients suggests that 
paraspinal positioning of electrodes is 
effective. 
Stimulation parameters in this 
treatment trial and other reported 
studies were determined by the type of 
TENS unit used. The Neuromod 
TENS unit used in this trial had a 
pulsed stimulus of 0.8msec at a 
frequency of 85Hz compared with 
0.2msec and 70Hz used by 
Mannheimer et al (1982 and 1985). 
The different parameters delivered by 
various TENS units should be 
considered if this treatment technique 
is to be used in the overall 
management of angina pectoris. It 
appears, from the results of this small 
trial, that these moderately high 
frequencies have a positive effect on 
the patient's experience of pain. 
Mannheimer et al (1990) reported that 
patients used high frequency TENS to 
avert angina in anticipated attacks but 
used low frequency TENS of the pulse 
train type stimulus for long term 
prevention. The present study used 
high frequency for the same effect with 
more comfort. 
It appears that at least six consecutive 
treatments should be undertaken 
before deciding on the effectiveness of 
this form of management for an 
individual. Although the generalised 
decrease in pulse rate and rate pressure 
product during TENS treatment may 
be attributable to rest, the reduction in 
frequency and severity of angina may 
reflect an improvement in the relative 
ischaemic state of the heart. The RPP 
has been shown to be a valid indicator 
of myocardial oxygen uptake (Kispert 
1987) for measures performed aUest. 
The results from this trial showed a 
highly significant reduction in RPP 
both at 30 and 90 minutes (p<0.005 
and p<O.OOl). Mannheimer et al (1985) 
also showed a reduction in the RPP 
when subjects were at rest and using 
TENS. This lowering of RPP is 
similar to the effect seen after beta 
adrenergic blockade withpropranalol 
(Gobel et al 1987) and upper thoracic 
sympathectomy (Mannheimer et al 
1982). A more recent study by 
Mannheimer et al (1990), showed that 
the anti-ischaemic and anti-anginal 
effect of TENS may have been 
explained by reduced sympathetic 
activity since arterial levels of 
epinephrine and norepinephrine and 
systolic blood pressure decreased 
during TENS stimulation during 
exercise. A single high dose of 
naloxone, a drug which blocks the 
effect of endogenous opioids, also 
fuiled to stop the beneficial effects of 
TENS in their study, showing that the 
effect was not solely due to TENS 
stimulating endogenous opioid release. 
Mannheimer et al (1990) had 
postulated that they might be 
responsible for the TENS effect on 
angina. However, a non-opioid 
mechanism may be responsible for the 
anti-ischaemic and anti-anginal effect 
of TENS as shown by an improved 
myocardial lactate metabolism 
(Mannheimer et al 1990). 
Although the results of this and other 
studies show that TENS is an effective 
treatment for chronic intractable 
angina pectoris, the mode of action of 
TENS on the heart is still obscure and 
ongoing research into its mode of 
action should be pursued. 
This treatment trial provides an 
indication that TENS is an effective 
method of reducing the frequency and 
severity of anginal episodes in patients 
with chronic intractable angina 
pectoris. This modality, therefore, 
should be considered as an adjunct to 
medical management for those patients 
who are not satisfactorily controlled by 
optimal medication. 
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